Geschäftsbericht der Lindenhofgruppe 2019

Thema Fachgebiet Ansprechperson Lindenhofgruppe Kooperations- partner /  Sponsor Sitzwachen: Evaluation von Faktoren, welche die 1:1- Betreuung und die Beziehungsgestaltung von Sitzwachen erleichtern oder erschweren. Pflege Sandra Peter Berner Fach- hochschule Implementation of the Symptom Navi © Program for cancer patients in ambulatory services: A cluster-randomized pilot study (Symptom Navi © Pilot Study, NAVI) Pflege, Onkologie, Hämatologie Susanne Kropf, Sabin Zürcher, Prof. Dr. med. Borner Markus HedS Fribourg Université de Lausanne A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation (TRANSPORT) Pneumologie Dr. med. Reta Fischer Biner Vertex Pharma- ceuticals A Phase 3, Randomized, Double-Blind, Controlled Study Evaluating the Efficacy and Safety of V X-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Heterozy- gous for the F508del Mutation and a Minimal Function Mutation (F / MF) Pneumologie Dr. med. Reta Fischer Biner Vertex Pharma- ceuticals A Phase 3, Open-label, Rollover Study to Evaluate the Safety and Efficacy of Longterm Treatment With V X-661 in Combi- nation With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Homozygous or Heterozygous for the F508del-CFTR Mutation Pneumologie Dr. med. Reta Fischer Biner Vertex Pharma- ceuticals A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of V X-659 Combination Therapy in Subjects WithCystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation Pneumologie Dr. med. Reta Fischer Biner Vertex Pharma- ceuticals Eine randomisierte, multizentrische, doppelblinde, placebo- kontrollierte klinische Studie der Phase III zur Beurteilung der Wirksamkeit und Sicherheit von intrathekal verabreich- tem RO7234292 (RG6042) bei Patienten mit manifester Huntington-Krankheit Radiologie Dr. med. Stefan Werlen Hoffmann- La Roche Registrierstudie beim Prostatakarzinom: «Swiss Prostate Brachytherapy Registry». Radio-Onkologie Dr. med. Armin Thöni Kantonsspital St. Gallen, Campus Stiftung Linden- hof Bern (SLB) Geschäftsbericht 2019 80 Lehre und Forschung